Plant-Based Protein Investment Accelerates as Plantible Secures $35M to Expand Production Five-Fold
Plantible Foods has secured $35 million in combined debt and equity financing to expand production of its Rubi Protein ingredient, highlighting growing investment in scalable plant-based protein technologies and alternatives to animal-derived functional ingredients.
The financing package includes a $25 million loan from X-Caliber Rural Capital through the U.S. Department of Agriculture's Business & Industry Loan Guarantee Program, alongside a $10 million equity investment from RA Capital and existing investors.
Plantible plans to use the funding to expand production at its Ranchito facility in Eldorado, Texas, with annual Rubi Protein capacity expected to increase five-fold to more than 1,000 metric tons. The company is adding new greenhouses and expects construction of the current expansion to be completed in early 2027.
Demand Is Outpacing Planned Capacity
The expansion comes as Plantible reports increasing demand from food manufacturers. According to co-founder and CEO Tony Martens, one customer recently doubled its order for 2027, meaning the company could still face a supply shortfall even after completing the planned expansion.
Plantible has also introduced a proprietary strain of Lemna, or water lentils, that has increased protein yield by more than 40%. An upgraded protein filtration system is expected to further improve the efficiency of converting biomass into commercially viable protein.
The company's ability to secure long-term offtake agreements and expand production through modular facilities has also helped strengthen investor confidence, according to the company.
From Alternative Protein to Functional Ingredient
Rubi Protein is derived from RuBisCO, one of the most abundant proteins found in green plants. Plantible produces it from Lemna grown in enclosed commercial greenhouses, allowing the company to operate a controlled crop cycle with less exposure to seasonal volatility and extreme weather.
The ingredient is notable not only for its nutritional profile but also for its functional properties, including emulsification, gelation and binding. This broadens its potential beyond traditional plant-based meat applications.
Plantible says Rubi Protein is being evaluated or used across applications including baked goods, confectionery, breadings, coatings, dairy products, sauces and dressings. It can also function as a clean-label binder and potential alternative to ingredients such as methylcellulose.
This functionality could become an important growth driver as food manufacturers look for ingredients that can simultaneously deliver protein content and technical performance.
Supply-Chain Volatility Creates Additional Demand
Plantible's expansion also reflects a broader challenge facing food ingredient manufacturers: dependence on a limited number of commodity protein sources.
Disruptions in egg and dairy protein supply, including avian influenza and shortages affecting whey, have increased interest in alternative ingredients that can provide both nutritional and functional properties.
Plantible's model also seeks to reduce exposure to agricultural volatility by growing Lemna in controlled environments. This could give manufacturers greater predictability in protein supply compared with conventional agricultural inputs that are more exposed to weather and seasonal conditions.
Regulatory Milestone Strengthens Commercial Position
The company's expansion follows a significant regulatory milestone. In February 2026, the U.S. Food and Drug Administration issued a "No Questions" letter confirming the Generally Recognized as Safe status of Rubi Protein for food applications.
Plantible says this represents the first FDA "No Questions" determination for isolated RuBisCO protein intended for food applications, potentially lowering a major barrier to broader commercial adoption.
What This Means for the Plant-Based Protein Market
Plantible's latest funding highlights an important evolution in the plant-based protein industry. Investment is increasingly moving beyond consumer-facing meat and dairy alternatives toward ingredient technologies capable of delivering nutrition, functionality and supply-chain resilience.
The company's five-fold capacity expansion also demonstrates the growing importance of scalable production infrastructure. If customer demand continues to exceed available supply, additional capital could flow into alternative protein processing and ingredient manufacturing capacity.
More broadly, increasing climate, disease and supply-chain volatility could encourage large ingredient companies to diversify away from concentrated commodity supply chains. This creates potential opportunities for emerging protein technologies and could also increase strategic acquisition activity as established ingredient companies seek access to new production platforms.
Brevintel Takeaway: Plantible's $35 million financing is more than a capacity expansion story. It signals growing commercial demand for next-generation plant proteins that can perform like conventional animal-derived ingredients while offering manufacturers greater supply flexibility. As these technologies move toward larger-scale production, investment, partnerships and M&A activity across the plant-based protein ingredient ecosystem could accelerate.